Cluster B personality disorders cannot be cured in the traditional sense, but they can go into remission. The distinction matters: remission means you no longer meet the diagnostic criteria for the disorder, while a cure would mean the underlying vulnerabilities are completely eliminated. Research over the past two decades shows that remission is not only possible but common for some Cluster B conditions, particularly borderline personality disorder. The picture is more complicated for narcissistic and antisocial personality disorders, where progress tends to be slower and harder to sustain.
What Remission Actually Means
Clinicians draw a clear line between remission and recovery. Remission means the acute symptoms, like intense emotional instability, impulsive behavior, or chronic emptiness, drop below the threshold needed for a formal diagnosis. Recovery is a higher bar: it requires remission plus a stable relationship, steady employment, and a reasonable level of day-to-day functioning. In a major longitudinal study of borderline personality disorder, only about half of participants met the full criteria for recovery at the 10-year mark, even though a much larger percentage had technically remitted. That gap highlights something important. You can stop meeting the diagnostic checklist while still struggling with relationships, work, or self-image.
Borderline Personality Disorder Has the Strongest Evidence
Of the four Cluster B disorders, borderline personality disorder (BPD) has the most treatment research and the most encouraging outcomes. A major 10-year follow-up study found that 85% of people with BPD achieved remission lasting at least 12 months. Relapse rates were surprisingly low: only about 12% of those who remitted went on to relapse, which is actually a lower relapse rate than major depression.
Several specialized therapies drive these outcomes. Dialectical behavior therapy (DBT) is the most widely studied, typically running about a year. It focuses on building skills for managing intense emotions, tolerating distress, and improving relationships. Mentalization-based treatment (MBT) runs longer, often 18 months to two years, and helps people better understand their own mental states and those of others. Transference-focused psychotherapy (TFP) works through the relationship with the therapist to reshape deep patterns of relating to people. All three approaches have published treatment protocols and are grounded in specific theories about what keeps BPD going.
Brain imaging research adds a biological dimension to these results. After completing DBT, people with BPD show measurable changes in the brain: reduced activity in the amygdala (the brain’s threat-detection center) and increased gray matter volume in areas responsible for impulse control and emotional regulation. These aren’t just behavioral changes. The brain itself is physically reorganizing in response to therapy.
Narcissistic Personality Disorder Improves Slowly
The outlook for narcissistic personality disorder (NPD) is more guarded. Longitudinal studies show that around 53% to 60% of people with NPD eventually no longer meet the full diagnostic criteria, but these changes happen gradually. Rapid improvement has not been documented in any study. Even among people who improve symptomatically, narcissistic patterns of thinking and relating to others tend to persist at a lower level.
The biggest obstacle is staying in treatment. Studies report a 63% to 64% dropout rate from psychotherapy among people with NPD. Several features of the disorder itself work against the therapeutic process. Perfectionism, shame, a tendency to devalue the therapist, and difficulty learning from experience all predict worse outcomes. Many people with NPD also experience their traits as a natural part of who they are rather than as a problem. When your personality feels normal to you, the motivation to change it is limited. Therapists working with NPD often describe “nontreatment treatments,” where sessions continue for months or years without meaningful change because clear goals were never set, or because the patient and therapist settle into a comfortable but unproductive dynamic.
For those who do remain in therapy, progress typically looks like a gradual softening of rigid patterns: less reactivity to perceived slights, more capacity for empathy, and fewer interpersonal crises. Full remission is possible but less predictable than with BPD.
Antisocial Personality Disorder Is the Hardest to Treat
Antisocial personality disorder (ASPD) presents the steepest challenge. Therapeutic goals for ASPD are generally more modest than for other Cluster B disorders, focusing on reducing aggression, impulsivity, substance abuse, and reoffending rather than achieving personality-level transformation. Follow-up studies show that some people with ASPD do reduce criminal behavior over time, but they often continue to have significant problems in their personal relationships even after behavioral improvements.
The core difficulty is similar to NPD but more pronounced: people with ASPD rarely see their behavior as a problem that needs fixing. Treatment is most often initiated through the criminal justice system or under external pressure rather than by personal choice. There is ongoing debate about the degree to which the deeper traits of ASPD, particularly those overlapping with psychopathy, are subject to meaningful change at all. The current evidence base is thin. A Cochrane review of psychological interventions for ASPD found that the available research could not yet confirm which specific therapies work, and called for future studies to use tools designed to measure actual clinical change rather than static personality traits.
Histrionic Personality Disorder Has Limited but Positive Data
Histrionic personality disorder (HPD) is the least studied of the Cluster B conditions, partly because it is diagnosed less frequently and partly because it often co-occurs with other personality disorders. The small body of research that does exist is encouraging. One study of a specialized approach called clarification-oriented psychotherapy found significant reductions in both disorder-specific symptoms and general psychological distress. A broader analysis of personality disorder treatments reported recovery rates of about 80% for schema-focused therapy and 60% for clarification-oriented psychotherapy over three years, compared to 50% for standard treatment, though these figures come from mixed personality disorder samples, not HPD alone.
Why Symptoms Often Fade With Age
Time itself plays a role. Research consistently shows that borderline and antisocial personality symptoms become less common in older adults. The impulsivity and emotional intensity that define much of Cluster B behavior in younger people tend to naturally diminish through middle age. This doesn’t mean the disorders vanish. About 10% of adults over 50 still meet criteria for a personality disorder, and even when acute symptoms decrease, the underlying personality patterns can continue to affect physical health and relationships. Think of it less as the disorder burning out and more as the most disruptive symptoms losing some of their edge while subtler difficulties remain.
Medication Manages Symptoms, Not the Disorder
No medication is approved by any regulatory agency for any Cluster B personality disorder. Medications are sometimes prescribed to manage specific symptoms like mood swings, anxiety, aggression, or impulsivity, but they target those symptoms rather than the personality disorder itself. A systematic review of pharmacological treatments for BPD found that antipsychotics, anticonvulsants, and antidepressants were not able to consistently reduce overall BPD severity. Medication is best understood as a supporting tool that can take the edge off certain symptoms enough for therapy to gain traction, not as a standalone treatment.
What Shapes Your Odds
Several factors influence how likely someone with a Cluster B disorder is to improve. The single most important one is whether the person recognizes their patterns as problematic. BPD, for all its severity, often causes enormous personal distress, which motivates people to seek and stay in treatment. NPD and ASPD, by contrast, frequently feel normal to the person experiencing them. When a trait feels like just “who you are,” the entire framework of treatment is harder to engage with. One of the early tasks in therapy for these conditions is helping the person begin to see their patterns from the outside.
Treatment duration also matters. Most specialized therapies run at least a year, and some of the best outcomes for BPD come from programs lasting 18 months to two years. Shorter treatments can still produce meaningful change, but personality-level shifts require sustained effort. The relationship with the therapist is itself a major vehicle for change, and building the kind of trust needed to challenge deep-seated patterns simply takes time.
Comorbid conditions complicate the picture. Paranoid thinking, substance use disorders, and antisocial traits alongside another Cluster B diagnosis all predict slower progress. On the other hand, having strong motivation, some capacity for self-reflection, and a willingness to tolerate discomfort in therapy all improve the outlook considerably.